loading
前日終値:
$3.05
開ける:
$3.07
24時間の取引高:
14,547
Relative Volume:
0.17
時価総額:
$121.62M
収益:
-
当期純損益:
$-78.92M
株価収益率:
-1.4657
EPS:
-2.04
ネットキャッシュフロー:
$-72.87M
1週間 パフォーマンス:
-5.97%
1か月 パフォーマンス:
-22.14%
6か月 パフォーマンス:
-14.57%
1年 パフォーマンス:
-8.56%
1日の値動き範囲:
Value
$2.96
$3.07
1週間の範囲:
Value
$2.89
$3.26
52週間の値動き範囲:
Value
$2.47
$6.06

Vigil Neuroscience Inc Stock (VIGL) Company Profile

Name
名前
Vigil Neuroscience Inc
Name
セクター
Healthcare (1195)
Name
電話
857-254-4445
Name
住所
100 FORGE ROAD, WATERTOWN
Name
職員
66
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
VIGL's Discussions on Twitter

VIGL を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
VIGL 2.99 121.62M 0 -78.92M -72.87M -2.04
VRTX 449.83 115.43B 10.63B -479.80M -1.35B 13.33
REGN 746.11 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 594.70 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 245.75 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 107.87 24.89B 3.30B -501.07M 1.03B 11.54

Vigil Neuroscience Inc Stock (VIGL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-03-31 開始されました Mizuho Buy
2022-09-16 開始されました Wedbush Outperform
2022-08-29 開始されました H.C. Wainwright Buy
2022-02-01 開始されました Guggenheim Buy
2022-02-01 開始されました Jefferies Buy
2022-02-01 開始されました Morgan Stanley Equal-Weight
2022-02-01 開始されました Stifel Buy
すべてを表示

Vigil Neuroscience Inc (VIGL) 最新ニュース

pulisher
Nov 15, 2024

Citadel Advisors LLC Adjusts Position in Vigil Neuroscience Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

Vigil Neuroscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 15, 2024
pulisher
Nov 14, 2024

Deep Track Capital, LP Increases Stake in Vigil Neuroscience Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 12, 2024

Vigil Neuroscience to Present at Upcoming Investor Conferences - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

Vigil Neuroscience Reports Third Quarter 2024 Financial Results and Provides Business UpdateOn November 7, 2024, Vigil Neuroscience, Inc. (NASDAQ: VIGL) released its financial results for the third quarter ended September 30, 2024. The company, dedic - Defense World

Nov 12, 2024
pulisher
Nov 11, 2024

Vigil Neuroscience’s (VIGL) “Buy” Rating Reiterated at HC Wainwright - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

Vigil Neuroscience (NASDAQ:VIGL) Price Target Raised to $24.00 - Defense World

Nov 11, 2024
pulisher
Nov 08, 2024

Vigil Neuroscience (NASDAQ:VIGL) Given New $24.00 Price Target at Wedbush - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

HC Wainwright Reiterates Buy Rating for Vigil Neuroscience (NASDAQ:VIGL) - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Vigil Neuroscience Advances Key Clinical Programs - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

Vigil Neuroscience Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Nov 07, 2024
pulisher
Nov 07, 2024

Vigil Neuroscience, Inc. (NASDAQ:VIGL) has caught the attention of institutional investors who hold a sizeable 41% stake - Yahoo Finance

Nov 07, 2024
pulisher
Nov 05, 2024

Vigil Neuroscience to Present at Guggenheim Healthcare Innovation Conference - GlobeNewswire

Nov 05, 2024
pulisher
Nov 05, 2024

abrdn plc Makes New $799,000 Investment in Vigil Neuroscience, Inc. (NASDAQ:VIGL) - MarketBeat

Nov 05, 2024
pulisher
Oct 17, 2024

We Think Vigil Neuroscience (NASDAQ:VIGL) Needs To Drive Business Growth Carefully - Simply Wall St

Oct 17, 2024
pulisher
Oct 09, 2024

Vigil Neuroscience retains stock target on TREM2 potential - Investing.com

Oct 09, 2024
pulisher
Oct 09, 2024

Vigil Neuroscience retains stock target on TREM2 potential By Investing.com - Investing.com Australia

Oct 09, 2024
pulisher
Oct 09, 2024

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Vigil Neuroscience, Inc. (NASDAQ: VIGL) - Victoria Advocate

Oct 09, 2024
pulisher
Oct 03, 2024

Quanterix Welcomes Ivana Magovčević-Liebisch, Ph.D., J.D. to Board of Directors - BioSpace

Oct 03, 2024
pulisher
Oct 02, 2024

Quanterix Appoints Ivana Magovčević-Liebisch to Board of Directors - citybiz

Oct 02, 2024
pulisher
Oct 02, 2024

Point72 Asset Management L.P. Buys New Position in Vigil Neuroscience, Inc. (NASDAQ:VIGL) - Defense World

Oct 02, 2024
pulisher
Oct 02, 2024

Point72 Asset Management L.P. Acquires New Position in Vigil Neuroscience, Inc. (NASDAQ:VIGL) - MarketBeat

Oct 02, 2024
pulisher
Sep 29, 2024

Vigil Neuroscience, Inc. (NASDAQ:VIGL) Shares Purchased by Ensign Peak Advisors Inc - MarketBeat

Sep 29, 2024
pulisher
Sep 27, 2024

Vigil Neuroscience, Inc. (NASDAQ:VIGL) Short Interest Down 20.3% in September - MarketBeat

Sep 27, 2024
pulisher
Sep 27, 2024

Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Sep 27, 2024
pulisher
Sep 23, 2024

Certified Advisory Corp Grows Stake in Vanguard Dividend Appreciation ETF (NYSEARCA:VIG) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Vanguard Dividend Appreciation ETF (NYSEARCA:VIG) Shares Purchased by Harmony Asset Management LLC - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Evergreen Capital Management LLC Sells 380 Shares of Vanguard Dividend Appreciation ETF (NYSEARCA:VIG) - Defense World

Sep 23, 2024
pulisher
Sep 22, 2024

Circle Wealth Management LLC Acquires 383 Shares of Vanguard Dividend Appreciation ETF (NYSEARCA:VIG) - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

Garden State Investment Advisory Services LLC Acquires 743 Shares of Vanguard Dividend Appreciation ETF (NYSEARCA:VIG) - Defense World

Sep 21, 2024
pulisher
Sep 20, 2024

VICOR 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Vicor CorporationVICR - Business Wire

Sep 20, 2024
pulisher
Sep 20, 2024

INVESTOR DEADLINE MONDAY: Robbins Geller Rudman & Dowd LLP Announces that Vicor Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – VICR - ForexTV.com

Sep 20, 2024
pulisher
Sep 20, 2024

Vigil Neuroscience shares maintain Outperform rating on positive FDA update - Investing.com

Sep 20, 2024
pulisher
Sep 19, 2024

WCG Wealth Advisors LLC Has $3 Million Position in Vanguard Dividend Appreciation ETF (NYSEARCA:VIG) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Bradley Foster & Sargent Inc. CT Cuts Position in Vanguard Dividend Appreciation ETF (NYSEARCA:VIG) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

1,275 Shares in Vanguard Dividend Appreciation ETF (NYSEARCA:VIG) Bought by One Capital Management LLC - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Vanguard Dividend Appreciation ETF (NYSEARCA:VIG) Shares Sold by ProVise Management Group LLC - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Vigil Neuroscience shares maintain Outperform rating on positive FDA update By Investing.com - Investing.com Australia

Sep 19, 2024
pulisher
Sep 18, 2024

FDA lifts partial clinical hold on Vigil Neuroscience’s Phase I VG-3927 trial - Clinical Trials Arena

Sep 18, 2024
pulisher
Sep 18, 2024

FDA lifts hold on Vigil Neuroscience's Alzheimer trial By Investing.com - Investing.com Canada

Sep 18, 2024
pulisher
Sep 17, 2024

Vigil Neuroscience Announces FDA Has Removed Partial Clinical Hold on VG-3927 - ForexTV.com

Sep 17, 2024
pulisher
Sep 17, 2024

Vigil stock gains as FDA removes partial hold (NASDAQ:VIGL) - Seeking Alpha

Sep 17, 2024
pulisher
Sep 17, 2024

FDA lifts hold on Vigil Neuroscience's Alzheimer trial - Investing.com India

Sep 17, 2024
pulisher
Sep 17, 2024

Vigil Neuroscience Advances Alzheimer’s Trial, Eyes 2025 Data - TipRanks

Sep 17, 2024
pulisher
Sep 17, 2024

Vigil Neuroscience Says FDA Lifts Partial Hold Alzheimer's-Treatment Trial - MarketWatch

Sep 17, 2024
pulisher
Sep 17, 2024

Vigil Neuroscience rises as FDA lifts partial hold on Alzheimer’s disease trial - XM

Sep 17, 2024
pulisher
Sep 16, 2024

The Neuroscience Market Research Explores 2024: Advancing Brain Research and Therapeutics - WhaTech

Sep 16, 2024
pulisher
Sep 16, 2024

Vigil Neuroscience to Present at Cantor Global Healthcare Conference - GlobeNewswire

Sep 16, 2024
pulisher
Sep 14, 2024

Vigil Neuroscience, Inc. (NASDAQ:VIGL) Short Interest Update - MarketBeat

Sep 14, 2024
pulisher
Sep 14, 2024

Vigil Neuroscience, Inc. (NASDAQ:VIGL) Short Interest Down 23.7% in August - Defense World

Sep 14, 2024
pulisher
Sep 10, 2024

Vigil Neuroscience (NASDAQ:VIGL) Trading 5% Higher - MarketBeat

Sep 10, 2024

Vigil Neuroscience Inc (VIGL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):